Previous Article | Next Article 
Journal of Virology, July 2000, p. 6637-6642, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mutations in the E1 Hydrophobic Domain of Rubella
Virus Impair Virus Infectivity but Not Virus Assembly
Zhiyong
Qiu,
Jiansheng
Yao,
Hanwei
Cao, and
Shirley
Gillam*
Department of Pathology and Laboratory
Medicine, Research Institute, University of British Columbia,
Vancouver, British Columbia V5Z 4H4, Canada
Received 11 February 2000/Accepted 20 April 2000
 |
ABSTRACT |
Rubella virus (RV) virions contain three structural proteins, a
capsid protein that interacts with viral genomic RNA to form a
nucleocapsid and two membrane glycoproteins, E2 and E1. We found that
substitution of either an aspartic acid residue at Gly93 (G93D) or a
glycine residue at Pro104 (P104G) in the internal hydrophobic domain of
E1 affected virus infectivity but not virus assembly. Viruses carrying
G93D and P104G mutations had impaired infectivity, reduced 1,000-fold
and 10-fold, respectively. A revertant was isolated from the G93D
mutant. Sequencing analysis showed that the substituted aspartic acid
residue in G93D mutant had reverted to the original glycine
residue, suggesting the involvement of Gly93 in membrane fusion during
viral entry.
 |
TEXT |
Rubella virus (RV), a
small enveloped positive-strand RNA virus, is the sole member of the
genus Rubivirus in the family Togaviridae (3). The RV virion contains a nucleocapsid consisting of a 40S genomic RNA molecule and a single species of capsid protein (33 kDa) (17). The nucleocapsid is enveloped within a
host-derived lipid bilayer containing two viral glycoproteins, E1 (58 kDa) and E2 (42 to 46 kDa) (16). The structural protein
genes are expressed from a 24S subgenomic RNA and are translated in the order NH2-C-E2-E1-COOH (18). RV matures by
budding at the plasma membrane of infected cells (1) and
enters uninfected cells by a membrane fusion process in the endosome
(6). Both processes are directed by E2-E1 heterodimers
(4, 27). Formation of an E2-E1 heterodimer is required for
transport of E1 out of the endoplasmic reticulum lumen to the Golgi and
plasma membrane (4).
Semliki Forest virus (SFV), a well-characterized alphavirus, uses an
acid-triggered membrane fusion to infect host cells. Its fusion with
cellular membranes is mediated by the viral spike proteins,
heterotrimers of two transmembrane subunits, E2 and E1, and a
peripheral protein, E3 (8, 25). Mutagenesis of an SFV spike
protein cDNA indicates that the internal hydrophobic domain of E1 is
closely involved in membrane fusion (12). Like SFV, RV
infects cells via a low-pH-dependent pathway (6, 9, 23).
Although little is known about the fusion process of RV, available
evidence suggests that RV E1 plays a dominant role in membrane fusion
(6, 27).
In previous studies, we constructed and characterized mutations within
the putative E1 fusion domain, 29 amino acid residues, extending from
amino acids 81 to 109 (Fig. 1). Mutants
generated in this domain were based on the rationale that substitution
of Cys82 by serine (C82S) would affect E2-E1 interaction, substitution of a charged aspartic acid at Gly93 (G93D) would inhibit the ability of
E1 to induce membrane fusion, and substitution of glycine for Pro104
(P104G) would disrupt the amphipathic and helix of fusion peptide.
Using a cDNA clone coding for E2 and E1 structural proteins, we
demonstrated that C82S mutation or deletion of this hydrophobic domain
(dt) of E1 (Fig. 1) resulted in disruption of E1 conformation that
ultimately impaired E1-E2 heterodimer formation and cell surface
expression of both E1 and E2 (27). However, both G93D and
P104G mutations were found to block neither E1-E2 heterodimer formation
nor the transport of E1 and E2 to the cell surface. No syncytium
formation was detected in cells expressing C82S, dt, and G93D
mutations, whereas the wild-type (wt) virus and P104G mutant exhibited
fusogenic activity, with 60% and 20 to 40%, respectively, of cells
fused at pH 4.8 (27). These studies were performed on RV E2
or E1 structural protein cloned into a plasmid, and the effects of
these mutations on virus assembly and infectivity could not be
determined.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic diagram of RV cDNA constructs and the
mutations introduced in the hydrophobic region of RV E1. E1, E2, and C
genes are indicated at the top. Signal peptides are indicated by open
boxes, and the transmembrane regions are shown by solid boxes. The E1
hydrophobic domain is shown. Beneath the arrows are the single amino
acid changes and the deletion mutation. 24S, the cDNA containing all
three structural protein genes of RV inserted in pNUT vector
(19) under the control of an inducible mouse metallothionein
promoter (mMT-1); E2E1, the cDNA containing the E1 and E2 genes in pNUT
vector. Restriction endonuclease sites: E, EcoRI; H,
HindIII; B, BamHI; N, NcoI; S,
SphI; and Bs, BstEII. nt, nucleotides.
|
|
In the present study, we incorporated G93D and P104G mutations into an
infectious RV cDNA clone and examined their effects on virus
infectivity. The effects of mutation on virus assembly were studied
using a system in which RV spike proteins can be assembled into RV-like
particles in the absence of virus replication (5, 20). We
found that virus assembly was not affected by G93D or P104G mutation,
but the mutants were 10-fold (P104G virus) and over 1,000-fold (G93D
virus) less infective than the wt virus. Passage experiments were
carried out to examine the reversion of mutant viruses harvested from
BHK cells transfected with RNA transcripts from mutants. In revertants
from G93D mutant virus, the substituted aspartic acid residue was found
to have changed to the original glycine residue. No revertant was
observed with P104G mutant virus.
Effects of mutations on virus assembly.
In SFV, mutations in
the putative fusion peptide of E1 glycoprotein confer a strong and
heat-reversible budding effect (2). The assembly of mutant
spike proteins into mature virions is severely impaired, and a cleaved
soluble fragment of E1 is released into the medium (2). In
our previous studies, we showed that in the fusion defective G93D
mutant, the E2-E1 heterodimers at the cell surface are unstable,
resulting in the release of cleaved E2 and E1 into the medium
(27). It is of interest to examine whether the assembly of
virus particles is also affected by the G93D mutation. Since G93D and
P104G mutations reside within the putative fusion peptide, we chose to
study virus assembly in the absence of virus replication, using the
capacity of RV structural proteins to form virus-like particles (VLPs)
(20). In this system, coordinated expression of capsid, E2,
and E1 proteins in stable transformed BHK cells (BHK-24S) results in
their assembly into VLPs in the absence of genomic RNA.
To isolate a stable BHK-24S cell line expressing the G93D or P104G
mutation, cDNA encoding the C protein was inserted into
plasmid
pNUT-E2E1 (G93D) or pNUT-E2E1 (P104G) (
27) by replacing
the
BstEII fragment with the
BstEII fragment from
pNUT-24S (Fig.
1). BHKtk

cells (
24) were
transfected with resultant plasmids by using
Lipofectin (Gibco/BRL),
and transformed cell lines were isolated
as described previously
(
20). Cell lines were named BHK-24S
(wt), BHK-24S (G93D),
and BHK-24S (P104G). To determine the effects
of G93D and P104G
mutations on VLP formation, pulse-chase experiments
were carried out.
Transformed BHK cells were preincubated with
growth medium containing
40 µM ZnSO
4 for 4 h to induce the expression
of RV
structural proteins from the metallothionein promoter (
20).
Cells were labeled with [
35S]methionine for 60 min and
chased with 1 mM unlabeled methionine
for 0, 2, 4, or 8 h. Labeled
RV proteins from cellular lysates
and culture media were
immunoprecipitated with human anti-RV serum.
Half of each sample was
treated with endo-

-
N-acetylglucosaminidase
H (endo H) to
monitor the processing of N-linked glycan (
21).
In wt and
both mutants, intracellular RV specific proteins the
sizes of E1 (58 kDa), C (33 kDa), and E2 (39 kDa) were detected,
migrating above the
capsid protein band; chase with unlabeled
methionine resulted in
conversion of E2 to a higher-molecular-mass
species (42 to 45 kDa) of
glycoprotein, while the sizes of E1
and C remained unchanged (Fig.
2A).

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 2.
Assembly of RV structural proteins into VLPs in BHK
cells. Transformed BHK cells were induced with ZnSO4 (40 µM) for 4 h prior to labeling. Induced BHK cells were labeled
with [35S]methionine and chased with unlabeled methionine
for 2, 4, and 8 h. Labeled RV proteins from cellular lysates (A)
and culture media (B) were immunoprecipitated with human anti-RV serum,
followed by SDS-PAGE. Lanes: B, BHK cells; Wt, BHK-24S (wt); G93D,
BHK-24S (G93D); P104G, BHK-24S (P104G). Positions of E1, E2, C, and
apparent molecular weight markers (in kilodaltons) are shown.
|
|
The release of RV structural proteins into the medium was found to
increase proportionally with the duration of chase in wt
and mutants
(Fig.
2B). E2 was found to resist endo H digestion,
while E1 was
partially endo H resistant (data not shown), suggesting
that both E2
and E1 had traversed through the Golgi complex and
to the cell surface
(
27). To confirm that RV structural proteins
in the medium
were VLPs that assembled into subviral particles
prior to their release
from the cells, media from wt and mutants
were subjected to
ultracentrifugation (350,000 ×
g for 20 min)
in the
presence or absence of 1% nonionic detergent Nonidet P-40
(NP-40).
Pellets were resuspended in phosphate-buffered saline
and subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE).
As expected, C, E2, and E1 were detected in the pellets
in the absence
of NP-40, but not in its presence (data not shown),
indicating that the
viral proteins were secreted as particles
sedimenting in a
gravitational field. These results indicate that
G93D and P104G
mutations did not affect the intracellular assembly
of mutant spike
proteins into
VLPs.
Since E1 is the hemagglutinin (HA) protein of RV, we were interested to
determine whether G93D and P104G mutations would affect
the HA
activity. Transformed BHK cells were grown in Dulbecco
modified Eagle
medium (DMEM) containing 3% fetal calf serum (FCS)
that had been
treated with kaolin to remove nonspecific inhibitors.
After 18 h
of induction with ZnSO
4, medium samples were collected
and
equal amounts of medium from wt, G93D, and P104G mutants were
subjected
to the conventional polyethylene glycol precipitation
procedure for
isolation of RV particles (
11). The pelleted VLPs
were
suspended in phosphate-buffered saline. The HA assay was
performed as
described by Liebhaber (
13), and the HA titer was
expressed
as the endpoint of serial dilutions of VLPs at which
erythrocyte
aggregation was observed. The VLPs from wt and both
mutants all
displayed HA activity of 32. Thus, G93D and P104G
mutations did not
interfere with the expression of HA activity
of
E1.
Effect of mutations on virus infectivity.
In our previous
studies (27), substitution of Gly93 residue by an aspartic
acid in the E1 hydrophobic region blocked syncytium formation without
affecting the transport of spike proteins to the cell surface. We
speculate that this mutation will be lethal in a virion, resulting in
the assembly of a nonfusogenic and noninfectious virion. However, it
has been shown in Moloney murine leukemia virus that fusion
accompanying viral entry and fusion responsible for syncytium formation
are independent processes in NIH3T3/DTras cells (26).
Therefore, the failure to induce syncytium formation does not necessarily correspond to the complete lack of fusion activity
in G93D mutant. To examine whether the G93D mutant could function in
the viral envelope to bring about cell infection, we introduced the
G93D and P104G mutations separately into an RV infectious full-length
cDNA clone, pBR/M33 (28). Initially the plasmid, pBR/M33
(XbaI/HindIII) containing part of the RV nonstructural protein genes and the entire structural protein genes
(nucleotides 4952 to 9762) was digested with restriction enzymes
SphI and BamHI, and the
SphI/BamHI fragment containing G93D or
P104G mutation (Fig. 1) was recloned into plasmid pBR/M33 (XbaI/HindIII) (minus the original
SphI/BamHI fragment). The resulting recombinant
plasmids containing G93D and P104G mutations were digested with enzymes
XbaI and HindIII, and the
XbaI/HindIII fragments containing G93D
and P104G mutations were isolated and inserted into pBR/M33 that had
its original XbaI/HindIII fragment deleted. DNA sequencing and restriction analysis were performed to confirm the
introduced mutations in the recombinant plasmids (pBR/M33/G93D and
pBR/M33/P104G).
Plasmids pBR/M33/G93D and pBR/M33/P104G were linearized at the unique
HindIII site, and the linearized DNAs were used as
templates
for synthesis of RNA transcripts. BHK cells were transfected
with
RNA by electroporation (
14). After transfection, the
culture
medium was harvested daily and replaced with fresh medium. The
released virus in the harvested medium was quantitated by plaque
assay.
The synthesis and assembly of RV structural proteins into
virus
particles were monitored by pulse-chase experiments. We
found that
protein species corresponding to RV E1 (58 kDa), E2
(37 to 45 kDa), and
C (33 kDa) were detected intracellularly for
the wt and both mutants
(Fig.
3A). At day 3 posttransfection,
the
levels of intracellularly expressed protein in both mutants
were
significantly reduced (Fig.
3A, day 3). In the culture medium,
the wt
virions were steadily released into the medium at days
1, 2, and 3 posttransfection, whereas in the mutants, particularly
G93D, a
significant reduction in the released virus was observed
at day 3 posttransfection (Fig.
3B). The reduction in virus release
in the
mutants could be attributed to the low capacity of mutant
viruses to
initiate infection in the second round of virus replication
(due to the
poor fusogenic properties of the mutant proteins)
and not to their
impaired virus assembly. If this were the case,
it would be expected
that the virus titers of G93D and P104G mutants
in the culture media
would be lower than that of the wt.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 3.
Synthesis of RV structural proteins in BHK cells
transfected with full-length RNA transcripts containing G93D and P104G
mutations by electroporation. Monolayers of BHK cells (35 mm) were
transfected with 2 µg of RNA transcript by electroporation. Culture
medium was harvested daily and replaced with fresh medium. Transfected
BHK cells were labeled with [35S]methionine for 3 h
and chased with unlabeled methionine for 18 h. Labeled RV proteins
from cellular lysates (A) and media (B) were immunoprecipitated with
human anti-RV serum. wt, wild-type M33 full-length infectious clone;
P104G, full-length infectious clone containing P104G mutation; G93D,
full-length infectious clone containing P104G mutation. Positions of
E1, E2, C, and apparent molecular weight markers (in kilodaltons) are
shown.
|
|
To determine the infectivity of G93D and P104G viruses, yields of virus
in harvested culture media were examined by plaque
assay
(
28). Virus titers for G93D and P104G mutants were
significantly
lower than for the wt (Table
1). That of G93D virus was 0.005%
of the
wt value at day 1 posttransfection and increased to 0.6%
of the wt
value at day 3 posttransfection. In the P104G mutant,
the titer was
about 10% of the wt value on all 3 days posttransfection.
To compare the defects in particle infectivity between wt and mutant
viruses, we determined the ratio of virus titer to virus
particles for
wt and mutant viruses. The amount of virus particles
in the culture
medium was quantitated by measuring the intensity
of radiolabel in E1
(Fig.
3B), using the Scion Image program for
Windows (beta 3b; the PC
version of the public domain NIH Image
program). As shown in Table
1,
the PFU/particle ratios clearly
show that both G93D and P104G viruses
are defective in particle
infectivity, and the particle infectivity of
wt and P104G viruses
remained fairly constant on all 3 days
posttransfection. Taken
together, our data suggest that both G93D and
P104G mutations
affect virus infectivity but not virus
assembly.
Analysis of G93D revertants.
We found that P104G virus formed
small plaques (0.5 mm in diameter) on Vero cells, whereas the plaques
of G93D virus were similar to those of wt (3 mm). It is likely that
G93D virus formed tiny plaques (due to defects in infectivity), and the
observed large-plaque morphology in plaque assay was due to the
occurrence of revertants after 6 days of incubation. RV replicates
slowly and forms microfocal plaques which are visible after 6 to 8 days of incubation.
The sharp increase in G93D virus titer at 3 days posttransfection as
well as the large-plaque phenotype of G93D virus suggest
a selection
for revertants of G93D mutation. As a low level of
virus was produced
in BHK cells transfected with G93D RNA by electroporation,
progeny were
passaged in Vero cells to isolate more viable revertants.
Vero cells
were infected with wt, P104G, or G93D virus (harvested
at day 3 posttransfection) at a multiplicity of 0.1 PFU/cell,
and virus
replication was monitored by pulse-chase experiments.
As shown in Fig.
4A, at days 1 and 2 postinfection, no
virus protein
was detected in the wt or mutants. However, low levels of
virus
were detected at day 3 posttransfection in wt and G93D mutant
viruses. At day 5 postinfection, similar high levels were released
into
the medium (Fig.
4B). The amount of released G93D virus was
comparable
to that of the wt. The released P104G virus was about
20% of the wt
value, indicating the emergence of revertant virus
in the G93D mutant.
To determine the nature of G93D virus reversion,
culture medium
harvested from day 5 posttransfection was inoculated
into a fresh
monolayer of Vero cells and incubated for 3 days.
After two more
passages, viral RNA was isolated from virus particles
and used for cDNA
synthesis and subsequent PCR amplification.
The sequence covering the
E1 hydrophobic region was determined
in three cDNA clones. In all three
sequenced cDNA clones, the
substituted aspartic acid residue (93D) had
reverted to the original
glycine residue. At present we cannot rule out
the possibility
of other second-site mutations in G93D revertants. No
revertant
was found in P104G virus stock. This result indicates that
the
Gly93 residue is critical in membrane fusion and that the increase
in virus titers of G93D mutant at days 2 and 3 posttransfection
was due
to the occurrence of G93D revertants.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 4.
Synthesis of RV structural proteins in Vero cells
infected with wt, P104G, and G93D viruses. Monolayers of Vero cells (35 mm) were infected with wt, P104G, or G93D virus harvested from BHK
cells at day 3 posttransfection at a multiplicity of 0.1 PFU/cell.
Infected cells were labeled with [35S]methionine for
3 h and chased with unlabeled methionine for 18 h. Labeled RV
proteins from cellular lysates and media were immunoprecipitated with
human anti-RV serum. (A) Lysates from infected Vero cells at day 1, 2, and 3 postinfection. (B) Labeled RV structural proteins from lysates
and media at day 5 postinfection. wt, wild-type M33 virus; P104G, P104G
virus; G93D, G93D virus. Positions of E1, E2, C, and apparent molecular
weight markers (in kilodaltons) are shown.
|
|
Fusion activities of the mutant viruses.
Since a low level of
infectious G93D virus was produced in BHK cells transfected with
full-length RNA transcript carrying the G93D mutation, it is possible
that the inability of G93D/E2E1 mutant protein to induce syncytium
formation (27) does not reflect a complete lack of fusion
activity. Therefore, we examined the pH dependence of virus-induced
polykaryon formation using mutant viruses harvested from BHK cells
transfected with infectious RNA transcripts. Vero cells were infected
with wt, G93D, or P104G virus, harvested at day 3 posttransfection at 1 PFU/cell, and incubated for 40 or 64 h at 37°C. The infected
cells were treated with fusion medium (pH 4.8) for 20 min at 37°C,
washed with growth medium (pH 7.0), and incubated with the growth
medium at 37°C for an additional 4 h. The polykaryons formed
were viewed under a phase-contrast microscope. At 40 h
postinfection, cultures of cells expressing the wt and P104G mutant had
60 and 10%, respectively, of fused cells, but no polykaryons were
observed with the G93D mutant (Fig. 5A to
C). At 64 h postinfection, cell lysis occurred in wt-infected
cells, and about 15 and 10% of fused cells were observed in the cell
cultures of P104G and G93D mutants, respectively (Fig. 5D). The
syncytium formation observed in G93D virus-infected cells could be
attributed to the presence of G93D revertants in virus stock. To
investigate this possibility, we analyzed the pH-dependent syncytium
formation of BHK cells expressing VLPs carrying the G93D mutation
(BHK-24S/G93D). Transformed BHK cells were incubated with growth medium
containing 40 µM zinc sulfate for 16 h to induce expression of
RV structural proteins (20). Induced BHK cells were treated
with fusion medium and incubated with growth medium as described above.
The percentages of fused cells observed were 50 to 60, 20, and 5% for
BHK-24S (wt), BHK-24S (P104G), and BHK-24S (G93D), respectively (data
not shown). It is interesting that a low level of polykaryons was
detected in BHK-24S (G93D) cells. The likely explanation for not
detecting polykaryon formation in E2E1 (G93D) mutant in the previous
studies (27) could be the instability of E2-E1 heterodimers
in the absence of capsid protein, as soluble E2 and E1 proteins were
observed in the medium after a longer time of chase (27).
These results indicate that G93D virus possesses a very limited
fusogenic activity that correlates well with its low virus infectivity.

View larger version (216K):
[in this window]
[in a new window]
|
FIG. 5.
Syncytium formation in Vero cells infected with wt,
P104G, and G93D viruses. Infected cells were exposed to fusion medium
at pH 4.8 for 20 min, incubated in regular growth medium for 4 h,
fixed, and photographed. Vero cells were infected with wt virus (A),
P104G virus (B), or G93D virus (C) at 40 h postinfection or with
G93D virus at 64 h postinfection (D).
|
|
The initial assay used to characterize the mutants described in this
study relied on the capacity of the spike proteins to
induce cell-cell
fusion in transformed BHK cell lines expressing
mutant E2 and E1
structural proteins (
27). To examine whether
mutant G93D
proteins that do not induce syncytium formation can
function in viral
entry, we incorporated the G93D mutation into
virus particles and
examined whether the resulting virions were
infectious. Similarly,
P104G mutant protein exhibiting limited
fusogenic activity was examined
for its effect on virus infectivity.
Alteration of the Pro104 residue
to glycine reduced virus infectivity
by 90%, whereas substitution of
an aspartic acid residue for glycine
resulted in a more dramatic drop
in virus infectivity (Table
1).
The low virus infectivity observed for
G93D and P104G mutant viruses
is due to the inability of the mutant
G93D and P104G viruses to
induce fusion of the viral envelope with an
intracellular membrane
to initiate infection in virus replication, not
to defects in
virus assembly or the low affinity of mutant protein to
bind Vero
cells. We found that the assembly of VLPs was not affected by
G93D and P104G mutations (Fig.
2), and in binding assays using
35S-labeled wt and mutant viruses, no difference in binding
efficiency
between the wt and mutant viruses was observed (data not
shown).
The endocytic entry mechanism predicts that viruses requiring a low pH
for fusion will be sensitive to inhibition by agents
that neutralize
endosomal pH. We have examined the entry properties
of RV by treatment
with NH
4Cl, a weak base widely used in studies
of the role
of low vacuolar pH, and found that RV replication
was inhibited by 90%
in the presence of 20 mM NH
4Cl prior to addition
of virus
to Vero cells and throughout virus entry and postentry
(data not
shown). Since NH
4Cl inhibits acidification of endosomes
(
15), this result suggests that RV infects cells by the
endosomal
pathway.
In SFV, mutations in the E1 putative fusion peptide were shown to shift
the pH threshold of cell-cell fusion (G91 to A), or
block cell-cell
fusion completely (G91 to D), when spike proteins
were transiently
expressed (
12). Use of the SFV infectious clone
revealed
that both mutations conferred a virus assembly defect
that was
partially reversible at 28°C (
2). G91A virus had limited
secondary infection and an acid-shifted fusion threshold, whereas
G91D
was defective and inactive in both cell-cell and virus-liposome
fusion
assay (
7). This differs from our finding in RV, in which
the
assembly of RV structural proteins into VLPs was not affected
by G93D
and P104G mutations. It is of interest that in both SFV-G91D
and
RV-G93D viruses, substitution of a charged aspartic acid for
glycine
blocks infectivity and cell-cell fusion
activity.
Many enveloped viruses, such as influenza virus and SFV, undergo fusion
within a cellular endocytic vesicle. Acidification
of the endosome is
thought to induce a conformational change of
a viral envelope
glycoprotein, which mediates the fusion event.
The requirement for
vesicular acidification for viral entry generally
assumes that a
similar environment is required for virus-mediated
cell fusion or
formation of syncytia. However, the inability to
induce syncytium
formation does not necessarily correspond to
complete lack of fusion
activity, as shown in Moloney murine leukemia
virus (
26).
This finding raises the possibility that different
epitopes on the
viral envelope glycoprotein may be involved in
these two fusion events.
In RV, the effect of NH
4Cl on virus entry
and the good
correlation between block in fusion activity and
virus infectivity
seems to indicate that the internal hydrophobic
domain of RV E1 is
involved both in cell fusion after virus entry
and in syncytium
formation.
In this study, we have shown that VLP assembly was not affected by G93D
and P104G mutations in RV E1. VLPs carrying either
G93D or P104G
mutation resembles the wt in HA activity. G93D virus
is barely
fusogenic and infectious with a high frequency of reversion
to wt.
Although the studies reported here do not permit us to
definitely
conclude that the E1 internal hydrophobic domain is
the fusion peptide
of RV, our evidence strongly suggests the direct
involvement of this
domain in fusion
events.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant from the Medical Research
Council of Canada. Zhiyong Qiu was the recipient of a Bertram M. Hoffmeister Fellowship Award. Shirley Gillam is an investigator of the
British Columbia's Children's Hospital Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department
of Pathology and Laboratory Medicine, University of British Columbia,
Research Institute, 950 W. 28th Ave., Vancouver, British Columbia V5Z
4H4, Canada. Phone: (604) 875-2474. Fax: (604) 875-2496. E-mail:
sgillam{at}interchange.ubc.ca.
Present address: Cardiovascular Research Laboratories, University
of California Los Angeles, Los Angeles, CA 90024-1760.
 |
REFERENCES |
| 1.
|
Bardeletti, G.,
J. Tektoff, and G. Gautheron.
1979.
Rubella virus maturation and production in two host cells systems.
Intervirology
11:97-103[Medline].
|
| 2.
|
Duffus, W. A.,
P. Levy-Mintz,
M. R. Klimjack, and M. Kielian.
1995.
Mutations in the putative fusion peptide of Semliki Forest virus affect spike protein oligomerization and virus assembly.
J. Virol.
69:2471-2479[Abstract].
|
| 3.
|
Francki, R. I. B.,
C. M. Fauquet,
D. L. Knudson, and F. Brown (ed.).
1991.
Classification and nomenclature of viruses. Fifth report of the International Committee on Taxonomy of Viruses. Archives of Virology, suppl. 2.
Springer-Verlag, Vienna, Austria.
|
| 4.
|
Hobman, T. C.,
M. L. Lundstrom, and S. Gillam.
1990.
Processing and transport of rubella virus structural proteins in COS cells.
Virology
178:122-133[CrossRef][Medline].
|
| 5.
|
Hobman, T. C.,
M. L. Lundstrom,
C. A. Mauracher,
L. Woodward,
S. Gillam, and M. G. Farquhar.
1994.
Assembly of rubella virus structural proteins into virus-like particles in transfected cells.
Virology
202:575-585.
|
| 6.
|
Katow, S., and A. Sugiura.
1988.
Low pH-induced conformational changes of rubella virus envelope proteins.
J. Gen. Virol.
69:2797-2807[Abstract/Free Full Text].
|
| 7.
|
Kielian, M.,
M. R. Klimjack,
S. Ghosh, and W. A. Duffus.
1996.
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus.
J. Cell Biol.
134:865-872.
|
| 8.
|
Kielian, M. C., and A. Helenius.
1986.
Entry of alphaviruses, p. 91-119.
In
S. Schlesinger, and M. J. Schlesinger (ed.), The Togaviridae and Flaviviridae. Plenum Publishing Corp., New York, N.Y.
|
| 9.
|
Kobayashi, N.
1978.
Hemolytic activity of rubella virus.
Virology
89:6610-6612.
|
| 10.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature (London)
227:680-685[CrossRef][Medline].
|
| 11.
|
Lee, J. Y.,
D. Hwang, and S. Gillam.
1996.
Dimerization of rubella virus capsid protein is not required for virus particle formation.
Virology
216:223-227[CrossRef][Medline].
|
| 12.
|
Levy-Mintz, P., and M. Kielian.
1991.
Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein.
J. Virol.
65:4292-4300[Abstract/Free Full Text].
|
| 13.
|
Liebhaber, H.
1970.
Measurement of rubella antibody by haemagglutination. I. Variables affecting rubella haemagglutination.
J. Immunol.
104:818-825[Abstract/Free Full Text].
|
| 14.
|
Liljestrom, P., and H. Garoff.
1991.
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon.
Bio/Technology
9:1356-1361[CrossRef][Medline].
|
| 15.
|
Mellman, I.,
R. Fuchs, and A. Helenius.
1986.
Acidification of the endocytic and exocytic pathways.
Annu. Rev. Biochem.
55:663-700[CrossRef][Medline].
|
| 16.
|
Oker-Blom, C.,
N. Kalkkinen,
L. Kaarianen, and R. F. Pettersson.
1983.
Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2, E2a, and E2b.
J. Virol.
46:964-973[Abstract/Free Full Text].
|
| 17.
|
Oker-Blom, C.,
N. Kalkkinen,
L. Kaarianen, and R. F. Pettersson.
1984.
Rubella virus 40S RNA specifies a 24S subgenomic RNA that codes for a precursor to structural proteins.
J. Virol.
49:403-408[Abstract/Free Full Text].
|
| 18.
|
Oker-Blom, C.
1984.
The gene order for rubella virus structural protein is NH2-C-E2-E1-COOH.
J. Virol.
51:354-358[Abstract/Free Full Text].
|
| 19.
|
Palmiter, R. D.,
R. R. Behringer,
C. J. Quaife,
F. Maxwell,
I. H. Maxwell, and R. I. Brinster.
1987.
Cell lineage ablation in transgenic mice by cell-specific expression of toxic gene.
Cell
50:435-443[CrossRef][Medline].
|
| 20.
|
Qiu, Z.,
D. Ou,
H. Wu,
T. C. Hobman, and S. Gillam.
1994.
Expression and characterization of virus-like particles containing rubella virus structural proteins.
J. Virol.
68:4086-4091[Abstract/Free Full Text].
|
| 21.
|
Tarentino, A. L., and F. Maley.
1974.
Purification and properties of an endo- -N-acetylglucosaminidase from Streptomyces griseus.
J. Biol. Chem.
249:811-817[Abstract/Free Full Text].
|
| 22.
|
Towbin, H.,
Y. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 23.
|
Vaananen, P., and L. Kaariaineen.
1980.
Fusion and haemolysis of erythrocytes caused by three togaviruses: Semliki Forest, Sindbis and rubella.
J. Gen. Virol.
46:467-475[Abstract/Free Full Text].
|
| 24.
|
Waechter, D. E., and R. Baserga.
1982.
Effect of methylation on expression of microinjected genes.
Proc. Natl. Acad. Sci. USA
79:1106-1110[Abstract/Free Full Text].
|
| 25.
|
Wahlberg, J. M.,
R. Bron, and H. Garoff.
1992.
Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein.
J. Virol.
66:7309-7318[Abstract/Free Full Text].
|
| 26.
|
Wilson, C. A.,
J. W. Marsh, and M. W. Eiden.
1992.
The requirements for viral entry differ from those for virally induced syncytium formation in NIH3T3/DTras cells exposed to Moloney murine leukemia virus.
J. Virol.
66:7262-7269[Abstract/Free Full Text].
|
| 27.
|
Yang, D.,
D. Hwang,
Z. Qiu, and S. Gillam.
1998.
Effects of mutations in rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity.
J. Virol.
72:8747-8755[Abstract/Free Full Text].
|
| 28.
|
Yao, J. S., and S. Gillam.
1999.
Mutational analysis, using a full-length cDNA clone of rubella virus, of rubella virus E1 transmembrane and cytoplasmic domains required for virus release.
J. Virol.
73:4622-4630[Abstract/Free Full Text].
|
Journal of Virology, July 2000, p. 6637-6642, Vol. 74, No. 14
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Claus, C., Hofmann, J., Uberla, K., Liebert, U. G.
(2006). Rubella virus pseudotypes and a cell-cell fusion assay as tools for functional analysis of the rubella virus E2 and E1 envelope glycoproteins.. J. Gen. Virol.
87: 3029-3037
[Abstract]
[Full Text]